<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898063</url>
  </required_header>
  <id_info>
    <org_study_id>20170967</org_study_id>
    <secondary_id>UL1TR002736</secondary_id>
    <nct_id>NCT03898063</nct_id>
  </id_info>
  <brief_title>90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status Disclosure</brief_title>
  <official_title>An Experimental Investigation of the Effects of an Entertainment Education Short Film on Internalized HIV-related Stigma, Sexual Partner Status Disclosure, and Medical Adherence Intentions Among Black HIV-positive Women in Miami-Dade County</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Advancing Translational Science (NCATS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation seeks to understand if and how, the 90 Days film can be used as an
      intervention to address HIV-related stigmas, intimate partner status disclosure and HIV ART
      medical adherence among Black HIV positive women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 17, 2019</start_date>
  <completion_date type="Actual">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants self-reporting HIV Status Disclosure</measure>
    <time_frame>Week 4</time_frame>
    <description>Self-report measure of whether participants told a sexual partner they are HIV positive (if applicable to their situation). Data obtained through follow-up survey administered by research team. Quantified in the manuscript as a dichotomous variable (0 = not disclosed; 1 = disclosed). Only counted among the subset of the participants who have a romantic partner that they have not yet disclosed their status to.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HIV self-stigmatization as assessed via Stigmatization Questionnaire</measure>
    <time_frame>4 weeks post-intervention</time_frame>
    <description>self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of stigmatization.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants' self-report estimates of their medical adherence as assessed through adherence questionnaires.</measure>
    <time_frame>Week 4</time_frame>
    <description>Self-report measure of perceptions of with medical recommendation adherence in the past 30 days. Assessed with three items asking participants to rate their ability to take their HIV medication over the past four weeks and their perceptions on whether they took their HIV medicine as prescribed in the past month (all items measured on a 6-pt scale where higher scores indicate better perceived medical adherence).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants' self-report estimates of their medical adherence as assessed through adherence questionnaires.</measure>
    <time_frame>Week 4</time_frame>
    <description>Self-report measure of the number of days participants were non-adherent with medical recommendations in the past 30 days. Assessed with one item asking participants the number of days (ranging from 0-30) they missed a dose of their HIV medicine in the past month with higher scores indicating increased nonadherence;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HIV self-stigmatization as assessed via Self Stigmatization Questionnaire</measure>
    <time_frame>Day 1 post test</time_frame>
    <description>self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of self-stigmatization.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participants will receive a standard-of-care brochure detailing HIV status disclosure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention 1: 90 DAYS film</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will watch the film, 90 DAYS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention 2: 90 DAYS film plus epilogue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will watch the film, 90 DAYS and also a brief epilogue created by the research team that connects key messages in the narrative and steps to enact safe disclosure</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>90 DAYS film</intervention_name>
    <description>the intervention conditions include exposure to a film, 90 DAYS (approx 20 minutes long), an entertainment film detailing a woman's decision to tell her romantic partner that she is HIV-positive.</description>
    <arm_group_label>intervention 1: 90 DAYS film</arm_group_label>
    <arm_group_label>intervention 2: 90 DAYS film plus epilogue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Film epilogue</intervention_name>
    <description>a 90-second epilogue developed by the research team making tangible connections between the film and one's own potential HIV status disclosure. Highlights safe strategies for disclosure.</description>
    <arm_group_label>intervention 2: 90 DAYS film plus epilogue</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIV pamphlet on disclosure</intervention_name>
    <description>A standard-of-care brochure given to newly diagnosed HIV patients about the importance of status disclosure</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Black women ages 18-50

          -  clinically diagnosed with HIV/AIDS

          -  Speak and comprehend English

        Exclusion Criteria:

          -  pregnant women
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Carcioppolo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami Medical Campus</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Nicholas Carcioppolo</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 4, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03898063/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

